G2M CAP CORP. ANNOUNCES UPSIZING OF CONCURRENT FINANCING AND DATE OF SPECIAL SHAREHOLDERS MEETING FOR QUALIFYING TRANSACTION WITH SALESCLOSER AI AND WISHPOND TECHNOLOGIES
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Concurrent Financing Upsized to $5,000,000 Due to Strong Investor... Read more.
Quinnipiac University Selects Unimarket to Consolidate and Modernize Source-to-Pay Operations
CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ — Unimarket, a global technology leader in source-to-pay solutions, today announced that Quinnipiac University... Read more.
FL6 Entertainment Expands Platform With Advanced AI Capabilities, White‑Label OTT, Global Localization, and Vertical‑First Production Tools
HOUSTON, Feb. 23, 2026 /PRNewswire/ — FL6 Entertainment announced the launch of its redesigned website and an expansion of its platform capabilities, reflecting... Read more.
Lightspeed TDMS Appoints Holly Miller as Head of Advisory Board at Pivotal Moment for Global Trade Settlement
LOS ANGELES, Feb. 23, 2026 /PRNewswire/ — Lightspeed Data Solutions, Inc., provider of Trade Date Management Services (TDMS), a post-trade software solution... Read more.
Pinnacol Assurance General Counsel Terry Leve Named “Global Market Leader” by Chambers, Highlighting World-Class Legal Expertise
DENVER, Feb. 23, 2026 /PRNewswire/ — Pinnacol Assurance, Colorado’s leading workers’ compensation insurer, announces that Chief Legal and Corporate... Read more.
Integris Composites developing armor for military in Arctic Circle
Announces Global Integris Arctic Armor Development Team (AADT) TYSONS CORNER, Va., Feb. 23, 2026 /PRNewswire/ — Returning from the annual meeting of its global... Read more.
Acromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International... Read more.
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation... Read more.
Haivision to Announce First Quarter Fiscal 2026 Financial Results on March 12, 2026
MONTREAL, Feb. 23, 2026 /PRNewswire/ – Haivision Systems Inc. (“Haivision“) (TSX: HAI), a leading global provider of mission critical, real-time... Read more.
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
– Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues – – Astellas to lead commercialization... Read more.